GUJRATHI SHEILA (Chief Strategy Officer) received a stock award from BOLT BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 10/27/2026ACC: 0001193125-26-434468
DirectorOfficer· Chief Strategy Officer
Since Oct 2026
+89.08K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
89.08K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+72.77K
Price / share
—
Trade value
—
% of position
New position
10/23/2026
0.00→72.77K
Common Stock
Indirect
Shares
+13.05K
Price / share
—
Trade value
—
% of position
New position
10/23/2026
0.00→13.05K
Total
Net shares
+85.82K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/23/2026 | A · Award | +72.77K | — | — | New position | 0.00 | 72.77K |
| Common Stock Indirect | 10/23/2026 | A · Award | +13.05K | — | — | New position | 0.00 | 13.05K |
| Total | +85.82K | $0.00 | ||||||
Derivative Transactions2
Series D Preferred Stock
Direct
Converts to
Common Stock
2.76M shares
Shares
+2.76K
Strike price
Held after
2.76K
Exercisable
—
10/23/2026
Series D Preferred Stock
Indirect
Converts to
Common Stock
495.87K shares
Shares
+495.87
Strike price
Held after
495.87
Exercisable
—
10/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series D Preferred Stock Direct | Common Stock2.76M shares | 10/23/2026 | J · J | +2.76K | — | 2.76K | |
| Series D Preferred Stock Indirect | Common Stock495.87K shares | 10/23/2026 | J · J | +495.87 | — | 495.87 |